Invesco’s Nektar Therapeutics NKTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$828K Sell
32,032
-9,516
-23% -$246K ﹤0.01% 2921
2025
Q1
$424K Sell
41,548
-2,154
-5% -$22K ﹤0.01% 3206
2024
Q4
$610K Buy
43,702
+581
+1% +$8.11K ﹤0.01% 3142
2024
Q3
$841K Buy
43,121
+173
+0.4% +$3.37K ﹤0.01% 2979
2024
Q2
$799K Buy
42,948
+7,858
+22% +$146K ﹤0.01% 3044
2024
Q1
$492K Buy
35,090
+14,830
+73% +$208K ﹤0.01% 3334
2023
Q4
$172K Sell
20,260
-3,696
-15% -$31.3K ﹤0.01% 3585
2023
Q3
$214K Sell
23,956
-345,073
-94% -$3.08M ﹤0.01% 3556
2023
Q2
$3.18M Sell
369,029
-2,129,810
-85% -$18.4M ﹤0.01% 2454
2023
Q1
$26.3M Buy
2,498,839
+10,341
+0.4% +$109K 0.01% 1212
2022
Q4
$84.4M Buy
2,488,498
+4,255
+0.2% +$144K 0.02% 758
2022
Q3
$119M Buy
2,484,243
+2,219
+0.1% +$107K 0.04% 603
2022
Q2
$141M Sell
2,482,024
-12
-0% -$684 0.04% 553
2022
Q1
$201M Buy
2,482,036
+22,603
+0.9% +$1.83M 0.05% 496
2021
Q4
$498M Buy
2,459,433
+81,354
+3% +$16.5M 0.12% 198
2021
Q3
$641M Buy
2,378,079
+854
+0% +$230K 0.16% 130
2021
Q2
$612M Buy
2,377,225
+13,932
+0.6% +$3.59M 0.15% 149
2021
Q1
$709M Sell
2,363,293
-504
-0% -$151K 0.19% 114
2020
Q4
$603M Sell
2,363,797
-15,620
-0.7% -$3.98M 0.18% 124
2020
Q3
$592M Buy
2,379,417
+167,374
+8% +$41.7M 0.2% 101
2020
Q2
$768M Sell
2,212,043
-49,384
-2% -$17.2M 0.27% 68
2020
Q1
$605M Buy
2,261,427
+152,818
+7% +$40.9M 0.25% 86
2019
Q4
$683M Sell
2,108,609
-200,950
-9% -$65.1M 0.21% 102
2019
Q3
$631M Buy
2,309,559
+753,358
+48% +$206M 0.17% 131
2019
Q2
$831M Buy
1,556,201
+1,421,782
+1,058% +$759M 0.21% 90
2019
Q1
$67.7M Buy
134,419
+13,929
+12% +$7.02M 0.02% 694
2018
Q4
$59.4M Buy
120,490
+8,658
+8% +$4.27M 0.02% 680
2018
Q3
$102M Sell
111,832
-29,196
-21% -$26.7M 0.03% 554
2018
Q2
$103M Buy
141,028
+39,818
+39% +$29.2M 0.03% 539
2018
Q1
$161M Sell
101,210
-29,353
-22% -$46.8M 0.06% 328
2017
Q4
$117M Sell
130,563
-110,287
-46% -$98.8M 0.04% 442
2017
Q3
$86.7M Sell
240,850
-86
-0% -$31K 0.03% 562
2017
Q2
$70.7M Sell
240,936
-43,094
-15% -$12.6M 0.02% 614
2017
Q1
$100M Sell
284,030
-11,891
-4% -$4.19M 0.03% 507
2016
Q4
$54.5M Buy
295,921
+6,080
+2% +$1.12M 0.02% 729
2016
Q3
$74.7M Buy
289,841
+1,648
+0.6% +$425K 0.03% 608
2016
Q2
$61.5M Sell
288,193
-6,634
-2% -$1.42M 0.02% 662
2016
Q1
$60.8M Buy
294,827
+3,073
+1% +$634K 0.02% 652
2015
Q4
$73.7M Buy
291,754
+11,922
+4% +$3.01M 0.03% 615
2015
Q3
$46M Buy
279,832
+11,003
+4% +$1.81M 0.02% 778
2015
Q2
$50.4M Buy
268,829
+25,980
+11% +$4.88M 0.02% 798
2015
Q1
$40.1M Sell
242,849
-32,795
-12% -$5.41M 0.02% 901
2014
Q4
$64.1M Buy
275,644
+153,127
+125% +$35.6M 0.02% 682
2014
Q3
$22.2M Buy
122,517
+70,205
+134% +$12.7M 0.01% 1141
2014
Q2
$10.1M Sell
52,312
-66,021
-56% -$12.7M ﹤0.01% 1549
2014
Q1
$21.5M Buy
118,333
+47,820
+68% +$8.69M 0.01% 1160
2013
Q4
$12M Buy
70,513
+25,307
+56% +$4.31M ﹤0.01% 1436
2013
Q3
$7.08M Buy
45,206
+44,333
+5,078% +$6.95M ﹤0.01% 1685
2013
Q2
$151K Buy
+873
New +$151K ﹤0.01% 3771